| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6e1cca234e807cdfce34464521405b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20ee6aa23e918ce5292e3065f4063930
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c0b34e4d8e04763ee1846c6c166dc7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23ab5139dc588b69c997b915cf69de95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9170f8250d3e3df237dbe17d5c616a |
| publicationDate |
2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007071947-A1 |
| titleOfInvention |
Cancer screening test |
| abstract |
The invention provides a cancer screening test, to identify patients having an increased likelihood of cancer, comprising the step of determining the presence or absence of members of a test group of tumour associated antigens in the blood of a patient. The test group comprises a plurality of tumour-associated antigens. Antigens of particular interest include Vascular Endothelial Growth Factor-A (VEGF A); CEA125 (Carcinoembryonic antigen 125); Prostate Specific Antigen (PSA); CA15-3 (Cancer antigen 15-3); CA125 (Cancer Antigen 125); CYFRA21-1 (Cytokeratin-19 fragments); Soluble ectodomain of c- erbB2; CA27.29 (Cancer Antigen 27.29); IGF-I (Insulin-like growth factor-1); IGF-2 (Insulin-like growth factor-2); and IGFBP-3 (Insulin-like growth factor binding protein 3). The invention also provides an antibody-based test kit to implement the screening method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9797905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3102946-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10539566-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101363868-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104583422-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101281198-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10261087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2867375-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103163293-A |
| priorityDate |
2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |